Category Archives: Guest Blog

Government-Funded Research: Is It That Different?

By Guest Blogger | Published: February 2, 2012
In December 2011, the President’s Bioethics Commission released its “Moral Science: Protecting Participants in Human Subjects Research.” The report was ordered by President Obama following an October 2010 revelation that the US Public Health Service supported unethical research in Guatemala from 1946 to 1948 that involved intentionally exposing thousands of Guatemalans to sexually transmitted diseases [...]
Also posted in R&D, Regulatory, Safety | Tagged , , , | Leave a comment

Roche Ups the Stakes on Personalized Medicine

By Guest Blogger | Published: February 1, 2012
By Patricia Van Arnum, Pharmaceutical Technology. Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry. Several pharmaceutical majors continue to invest in this emerging field as evident by Roche’s $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics.
Also posted in Biotech, Europe, Global | Tagged , , | Leave a comment

Pharma: Get Ready for the New Supply Chains

By Guest Blogger | Published: January 30, 2012
New pharma supply chains, where chill control and traceability challenges will be far more critical, will emerge over the next decade, So it’s time, argues Julian Mosquera, for the industry to upgrade its capabilities. The pharmaceuticals industry is undergoing major disruption and every comparative benchmark indicates that the sector needs to make a step change in [...]
Also posted in Global, Safety, Supply Chain | Tagged , , | 1 Comment

JP Morgan Healthcare Conference Marked by Uncertainty

By Guest Blogger | Published: January 12, 2012
2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of investment banking [...]
Also posted in R&D, Strategy, healthcare | Tagged , , , , | 2 Comments

The 'S' Word in Healthcare Reform

By Guest Blogger | Published: December 19, 2011
by Tom Norton In little more than two years, the main elements of the HCR will take hold across the nation.  As implementation continues to ramp up, one of the more intriguing questions surrounding its activation is, is the “S” word being realized?…That is, “S” as in “savings.” Are the much publicized “savings” that were projected [...]
Also posted in Regulatory, Strategy, healthcare | Tagged , , , , , | 3 Comments